Pharmacy Board bans sale of anti-malaria drugs amid coronavirus surge

The Pharmacy and Poisons Board has banned the sale of chloroquine and Hydroxychloroquine by pharmacies to Kenyans who do not have a prescription from a medical doctor.

This comes amidst a spike in the purchase of the drugs after claims emerged that they can be used to treat the coronavirus.

On Thursday, The Board’s CEO, Dr. Fred Siyoi, warned that the use of the drugs to persons who are unauthorized to use them would lead to irreversible effects like blindness.
“Please note that clinical trials utilizing the two medicines are currently ongoing and no robust clinical data substantiating their use fro prophylaxis and curative purpose is available hence caution has to be applied when using them,” he said.

He noted that their purchase to persons who have no ailments such as rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea tarda that require such treatment risk endangering the lives of those who need the drugs.